Adverse drug reactions and associated factors in patients taking levothyroxine and antithyroid drugs at Northwest hospitals, Ethiopia: A cross-sectional study

Read full text Summarise with VIRAT
Authors: Fisseha Nigussie Dagnew, Bayih Endalew Bitew, Getachew Yitayew Tarekegn, Tilaye Arega Moges, Samuel Agegnew Wondm, Sisay Sitotaw Anberbr, Sintayehu Simie Tsega, Woretaw Sisay Zewdu, Zufan Alamrie Asmare
Cited by: 0
References: 62

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Thyroid disease is a type of endocrinologic disease that should be treated early to avoid thyroid disease-related comorbidities, especially cardiovascular complications secondary to hyperthyroidism, which requires medication therapy to achieve an euthyroid state. However, patients are exposed to medication-related adverse drug reactions (ADRs) while taking drugs to treat thyroid disease. ADRs are unpredictable and unintended medication effects on the patient. Objective: This study aimed to determine the prevalence and severity of ADRs and the contributing factors of medications used for treating thyroid disease. Design: A cross-sectional study. Method: A multicenter, hospital-based study was conducted through patient interviews at public hospitals in Northwest Ethiopia. A simple random sampling technique was used to identify patients for the interview. The ADR was assessed using the Naranjo algorithm of the ADR probability scale, and the Shamrock severity of ADR assessment tool was used to identify ADR. STATA version 17 was used for data analysis. The results were summarized using descriptive statistics, including frequency, mean, median, and standard deviation. To identify the independent predictors of ADRs, logistic regression analysis was conducted, and a p -value

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Thyroid Disorders and Treatments Pharmaceutical Practices and Patient Outcomes

Publication details

Journal / source
Sage Open Chronic Disease
Volume
17
Pages
27558428261421490–27558428261421490
Publication date
1 February 2026
Language
EN